First Quadrant’s Haemonetics HAE Stock Holding History

First Quadrant’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-570	Closed	-$63K	–	552
2021 Q1	$63K	Hold	570	–	–	0.01%	449
2020 Q4	$68K	Hold	570	–	–	0.01%	442
2020 Q3	$50K	Sell	570 -939	-62%	-$82.1K	0.01%	490
2020 Q2	$135K	Sell	1,509 -367	-20%	-$37.1K	0.02%	480
2020 Q1	$187K	Buy	1,876 +1,306	+229%	+$142K	0.03%	389
2019 Q4	$65K	Hold	570	–	–	0.01%	504
2019 Q3	$72K	Hold	570	–	–	0.01%	508
2019 Q2	$69K	Hold	570	–	–	﹤0.01%	609
2019 Q1	$50K	Sell	570 -11,666	-95%	-$1.06M	﹤0.01%	639
2018 Q4	$1.22M	Sell	12,236 -180,099	-94%	-$18.9M	0.1%	211
2018 Q3	$22M	Buy	192,335 +90,179	+88%	+$9.34M	0.49%	48
2018 Q2	$9.16M	Buy	102,156 +92,728	+984%	+$7.83M	0.17%	175
2018 Q1	$690K	Sell	9,428 -32	-0.3%	-$2.2K	0.01%	442
2017 Q4	$549K	Buy	9,460 +571	+6%	+$30.1K	0.01%	526
2017 Q3	$399K	Sell	8,889 -41	-0.5%	-$1.7K	0.01%	594
2017 Q2	$353K	Sell	8,930 -2,870	-24%	-$118K	0.01%	598
2017 Q1	$479K	Hold	11,800	–	–	0.01%	539
2016 Q4	$474K	Hold	11,800	–	–	0.01%	544
2016 Q3	$427K	Hold	11,800	–	–	0.01%	561
2016 Q2	$342K	Buy	+11,800	New	+$357K	0.01%	533

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

First Quadrant's HAE Position: Q2 2021 in Review

First Quadrant sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 570 shares — an estimated $63K sold.

First Quadrant first reported a position in HAE in Q2 2016 and held it in 20 quarters. The position peaked at $22M in Q3 2018. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

First Quadrant reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
First Quadrant sold 570 Haemonetics shares in Q2 2021, an estimated $63K.
First Quadrant first reported a position in Haemonetics in Q2 2016 and held it in 20 quarters.
First Quadrant's Haemonetics position peaked at $22M in Q3 2018.
258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on First Quadrant's 13F filing for Q2 2021, filed 23 Jul 2021.